Marco Londei, Chief Medical Officer at ANAPTYSBIO INC (ANAB), sold 20,120 shares at $72.45 ($1.5M) on 2019-06-04, disclosed to the SEC on 2019-06-05.
Open-market sale of $1.5M ANAB by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $72.45 | 6,009 | $435K | 29.6% |
| 2 | $72.45 | 6,009 | $435K | 29.6% |
| 3 | $73.43 | 2,048 | $150K | 10.2% |
| 4 | $73.43 | 2,048 | $150K | 10.2% |
| 5 | $74.50 | 2,003 | $149K | 10.2% |
| 6 | $74.50 | 2,003 |
| $149K |
| 10.2% |
| Total | $73.06 avg | 20,120 | $1.5M | 100% |
| Filing → |